Literature DB >> 2407341

Terminal dehydration. To give or not to give intravenous fluids?

C F Musgrave1.   

Abstract

The question of whether or not to give intravenous fluids to cancer patients who are in the last stages of their illness is one that has become problematic to health professionals, particularly those working in terminal-care settings. This article attempts to give a better understanding of the subject by unraveling some of the issues involved. The different types of dehydration and the signs and symptoms that may be experienced by dying patients who are dehydrated are defined. Some of the beneficial effects, as well as the ill effects, that such dehydration may cause are delineated. An analysis is made of health professionals' attitudes to dehydration in dying cancer patients and the special ethical problems associated with the question. There is then a practical synthesis of these facts into the formation of guidelines to facilitate the decision-making process related to the initiation of parenteral fluids in dying patients, and a discussion on the law as it pertains to the treatment of dehydration in such patients.

Entities:  

Keywords:  Death and Euthanasia

Mesh:

Year:  1990        PMID: 2407341

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  4 in total

Review 1.  Preventing crises in palliative care in the home. Role of family physicians and nurses.

Authors:  G Howarth; K B Willison
Journal:  Can Fam Physician       Date:  1995-03       Impact factor: 3.275

2.  ["Terminal" dehydration, part 1 : Differential diagnosis and body of evidence].

Authors:  U Suchner; C Reudelsterz; C Gog
Journal:  Anaesthesist       Date:  2018-09       Impact factor: 1.041

Review 3.  How to manage terminal dehydration.

Authors:  U Suchner; C Reudelsterz; C Gog
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

4.  Ensuring competency in end-of-life care: controlling symptoms.

Authors:  Frank D Ferris; Charles F Von Gunten; Linda L Emanuel
Journal:  BMC Palliat Care       Date:  2002-07-30       Impact factor: 3.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.